Contract Service Directory


KBI Biopharma, Inc.





Company Headquarters

1101 Hamlin Road
Durham, NC 27794
United States

Contract Service Directory

    Related Content

    • Bio News | Breaking News | Industry News | Promotions & Moves
      Vibalogics Advances Growth with Leadership Hires

      Vibalogics Advances Growth with Leadership Hires

      Pharma industry vet Roger Lias joins the CDMO as chief commercial officer.
      07.16.21

    • Analytical Services | Breaking News | cGMP Manufacture | Collaborations & Alliances | Formulation Development
      Selexis, KBI Biopharma, Immatics Partner to Advance TCR Program

      Selexis, KBI Biopharma, Immatics Partner to Advance TCR Program

      Will leverage integrated services from Selexis and KBI as part of Immatics’ development of TCR Bispecifics, designed to detect, target and attack tumor cells.
      06.30.21

    • Breaking News | Collaborations & Alliances | Industry News
      KBI Biopharma, AM-Pharma Enter Manufacturing Agreement

      KBI Biopharma, AM-Pharma Enter Manufacturing Agreement

      Partnership supports future commercial manufacturing for AM-Pharma’s potential kidney disease treatment.
      06.17.21


    • Bioanalytical Services | Breaking News | cGMP Manufacture | Industry News
      KBI Biopharma Expands U.S. Ops

      KBI Biopharma Expands U.S. Ops

      Invests $150 million in commercial biologics manufacturing facility in RTP, NC.
      Contract Pharma Staff 12.02.20

    • Bioanalytical Services | cGMP Manufacture | Drug Development | Scale-up/Technology Transfer
      CDMOs: Keeping up with Science & Technology

      CDMOs: Keeping up with Science & Technology

      Enhancing the development of increasingly advanced and complex drug candidates is needed to drive growth in the industry.
      Kristin Brooks, Contract Pharma 11.12.20

    • APIs | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      JSR Life Sciences Expands European Footprint

      JSR Life Sciences Expands European Footprint

      Will co-locate primary European operations for affiliate companies KBI Biopharma and Selexis SA in Geneva’s ZIPLO campus.
      10.20.20


    • Breaking News | cGMP Manufacture | Facilities | Industry News | Solid Dosage/Creams/Ointments
      Quad Technologies Expands After New HQ, Lab Move

      Quad Technologies Expands After New HQ, Lab Move

      The company says the move "changes the game" for Quad Technologies and its customers
      11.29.17

    • CRO News | Promotions & Moves
      PAREXEL Appoints Three New Vice Presidents

      PAREXEL Appoints Three New Vice Presidents

      The new hires come from the FDA and Oncology industry positions
      11.15.17



    • Biologics, Proteins, Vaccines
      CEO Spotlight:  Samsung Biologics

      CEO Spotlight: Samsung Biologics

      A conversation with Samung Biologics CEO, Dr. TH Kim
      Tim Wright, Contract Pharma 10.11.17

    • Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Industry News | Scale-up/Technology Transfer
      Heat Biologics, KBI Biopharma Enter Development/Mfg. Pact

      Heat Biologics, KBI Biopharma Enter Development/Mfg. Pact

      KBI Biopharma to provide development and manufacturing services for cancer immunotherapies
      09.28.17

    • Biologics, Proteins, Vaccines

      Vaccine Manufacture: It’s Complicated

      GSK takes you through the stages of vaccine manufacture from development to distribution


    • Biologics, Proteins, Vaccines | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Industry News
      Ajinomoto Althea Opens GMP Mfg. Suites

      Ajinomoto Althea Opens GMP Mfg. Suites

      To develop and manufacture ADCs and HPAPIs
      09.19.17

    • Clinical Trials | CRO News
      PAREXEL Launches Real-World Data Service Offering

      PAREXEL Launches Real-World Data Service Offering

      Aims to help drive value demonstration of new treatments
      09.06.17

    • Breaking News | Facilities | Industry News
      Alcami to Move HQ

      Alcami to Move HQ

      Plans call for the relocation of global headquarters to Research Triangle Park in 2018
      07.17.17

    • Bioanalytical Services | Biosimilars
      The Analytical Challenges of the Biosimilar Boom

      The Analytical Challenges of the Biosimilar Boom

      The growing biosimilar industry and its implications on the current drug market
      Mario DiPaola, Senior Scientific Director, Charles River Laboratories 07.03.17